Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Rosuvastatin on Risk Markers of Venous Thromboembolism During Systemic Therapy for Advanced Cancer

NCT01524653 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.

NCT NCT01524653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01524653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Rosuvastatin on Risk Markers of Venous Thromboembolism During Systemic Therapy for Advanced Cancer
Lead sponsor
University of Vermont
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
September 1, 2016
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, neoplasms, venous thromboembolism